期刊文献+

HRCT对特发性肺间质纤维化的鉴别诊断价值临床研究 被引量:5

Clinical Study of Differential Diagnosis Value of HRCT on Idiopathic Pulmonary Interstitial Fibrosis
下载PDF
导出
摘要 目的分析HRCT(高分辨率CT)对特发性肺间质纤维化的诊断价值。方法回顾收集经病理证实的56例特发性间质性肺炎患者影像学资料,患者均进行HRCT扫描,根据扫描结果判断疾病分布,并分析不同时期的成像特点。结果 HRCT主要表现有磨玻璃样阴影改变、网状改变、蜂窝状改变、胸膜下间质纤维化等特点,本次56例患者中,46.4%为早期患者,HRCT图像表现为磨玻璃样、小叶内间质增厚、小叶间隔增厚表现;53.6%为非早期患者,除上述症状,还出现胸膜下弧线影及蜂窝肺,其中小叶间隔增厚所占比例最高。结论不同时期的特发性肺间质纤维化HRCT各有特点,其成像结果能有效反映病变情况,可用于特发性肺间质纤维化鉴别诊断。 Objective To analyze the diagnostic value of HRCT(high resolution CT)on idiopathic pulmonary fibrosis.Methods The imaging data of 56 patients with idiopathic interstitial pneumonia confirmed by pathology were retrospectively collected.All patients were given HRCT scan.The disease distribution was judged according to the scan results,and the imaging characteristics of different periods were analyzed.Results HRCT showed the ground glass-like shadow change,reticular change,honeycomb change and subpleural interstitial fibrosis.Among the 56 patients,46.4%were early patients,and the HRCT images showed ground glass,intralobular interstitial thickening and interlobular septal thickening.And 53.6%were non-early patients,and the images showed subpleural arc shadow and honeycomb lung in addition to the above symptoms,and the percentage of interlobular septal thickening was the highest.Conclusion The HRCT of idiopathic pulmonary interstitial fibrosis in different periods has its own characteristics.And its imaging results can effectively reflect the lesions and can be used for the differential diagnosis of idiopathic pulmonary interstitial fibrosis.
作者 马磊 MA Lei(CT Room,The Second People's Hospital of Xinxiang,Xinxiang 453000,Henan Province,China)
出处 《罕少疾病杂志》 2019年第2期41-42,45,共3页 Journal of Rare and Uncommon Diseases
关键词 高分辨率CT 肺间质纤维化 诊断 High Resolution CT Pulmonary Interstitial Fibrosis Diagnosis
  • 相关文献

参考文献9

二级参考文献71

  • 1江平,刘锦铭,易祥华.电视辅助胸腔镜肺手术对特发性间质性肺炎的诊断价值[J].临床内科杂志,2006,23(6):420-421. 被引量:3
  • 2易祥华.重视间质性肺疾病的病理学[J].中华病理学杂志,2006,35(7):386-388. 被引量:20
  • 3赵亚东,李振华,康健,侯显明,于润江.特发性肺纤维化患者血清及支气管肺泡灌洗液中KL-6水平及其意义[J].中华内科杂志,2007,46(2):151-152. 被引量:9
  • 4Wilson KC, Raghu G. The 2015 guidelines for idiopathic pulmonary fibrosis: an important chapter in the evolution of the management of patients with IPF [ J]. Eur Respir J, 2015, 46 (4) :883-886.
  • 5Ley B, Brown KK, Collard HR. Molecular biomarkers in idiopathic pulmonary fibrosis [ J ]. Am J Physiol Lung Cell Mol Physiol, 2014, 307 ( 9 ) : L681-L691.
  • 6Huang H, Peng X, Nakajima J. Advances in the study of biomarkers of idiopathic pulmonary fibrosis in Japan [ J ]. Biosci Trends,2013,7 (4) :172-177.
  • 7Kinder B W, Brown KK, Mccormack FX, et al. Serum surfactant protein-A is a strong predictor of early mortality in idiopathic pulmonary fibrosis[ J]. Chest, 2009,135 (6) : 1557-1563.
  • 8Okamoto T, Fujii M, Furusawa H, et al. The usefulness of KL-6 and SP-D for the diagnosis and management of chronic hypersensitivity pneumonitis [ J ]. Respir Med, 2015.
  • 9Kohno N. Serum marker KL-6/MUC1 for the diagnosis and management of interstitial pneumonitis [ J~. J Med Invest, 1999, 46(3-4) :151-158.
  • 10Bonella F, Costabel U. Biomarkers in connective tissue disease- associated interstitial lung disease [ J ]. Semin Respir Crit Care Med,2014,35(2) :181-200.

共引文献98

同被引文献41

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部